Provectus Biopharmaceuticals (PVCT) Free Cash Flow (2010 - 2025)
Provectus Biopharmaceuticals (PVCT) reported Free Cash Flow of -$869,553 for Q4 2025, compared with -$912,008 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Free Cash Flow (2010 - 2025) Analysis & Trends
For FY2025, Provectus Biopharmaceuticals posted Free Cash Flow of -$3.33 million.
- By year, Free Cash Flow came in at -$3.28 million in FY2024, -$2.57 million in FY2023, -$3.04 million in FY2022 and -$1.01 million in FY2021.
- Five-year quarterly Free Cash Flow spans a low of -$1.11 million in Q1 2021 and a high of $1.62 million in Q4 2021.
- Per Business Quant data, the three quarters before Q4 2025 came in at -$839,867 (Q3 2025), -$523,127 (Q2 2025) and -$1.09 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -869,553.00 |
| Sep 30, 2025 | -839,867.00 |
| Jun 30, 2025 | -523,127.00 |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -912,008.00 |
| Sep 30, 2024 | -565,003.00 |
| Jun 30, 2024 | -762,585.00 |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | -561,211.00 |
| Sep 30, 2023 | -768,874.00 |
| Jun 30, 2023 | -617,783.00 |
| Mar 31, 2023 | -624,110.00 |
| Dec 31, 2022 | -754,790.00 |
| Sep 30, 2022 | -816,578.00 |
| Jun 30, 2022 | -877,885.00 |
| Mar 31, 2022 | -592,219.00 |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | -815,662.00 |
| Jun 30, 2021 | -706,139.00 |
| Mar 31, 2021 | -1.11 Mn |
API Access
Provectus Biopharmaceuticals Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();